MedTrace Logo

Obese Human Beta-2-adrenergic Stimulation and Muscle Glucose Uptake

NCT04921306 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2024-05-07

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of four weeks clenbuterol/placebo supplementation on skeletal muscle glucose disposal in overweight/obese male and (postmenopausal) female volunteers.

Conditions

Interventions

DRUG

Clenbuterol Hydrochloride

Daily ingestion of clenbuterol hydrochloride capsules (40 microgram/day) for a total period of 28 days with a wash-out period of at least 6-8 weeks.

DRUG

Placebo

Daily ingestion of placebo capsules for a total period of 28 days with a wash-out period of at least 6-8 weeks.

Sponsors & Collaborators

  • Eurostars

    collaborator OTHER

  • Maastricht University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-16
Primary Completion
2024-03-01
Completion
2024-03-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04921306 on ClinicalTrials.gov